ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Katherine Van Loon
Matched on ORCID iD 0000-0002-9705-4114; OpenAlex author ID A5009593313. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper
Papers 4
- The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. Co-author DOI 10.1371/journal.pone.0202272↗
- Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective tria… Co-author DOI 10.1002/cncr.28648↗
- 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). Co-author DOI 10.1093/jnci/dju185↗
- Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-con… Co-author DOI 10.1097/mpa.0000000000000095↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Federico Innocenti · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Kouros Owzar · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Chen Jiang · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Hedy Lee Kindler · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Alan Paul Venook · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Andrew H. Ko · 2 shared papers, 2014 · strength 0.08
- Paper Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab:… DOI 10.1002/cncr.28648↗
- Paper Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analys… DOI 10.1097/mpa.0000000000000095↗
- Renuka V. Iyer · 2 shared papers, 2014 · strength 0.08
- Paper Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab:… DOI 10.1002/cncr.28648↗
- Paper Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analys… DOI 10.1097/mpa.0000000000000095↗
- Tanios Bekaii‐Saab · 2 shared papers, 2014 · strength 0.08
- Paper Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab:… DOI 10.1002/cncr.28648↗
- Paper Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analys… DOI 10.1097/mpa.0000000000000095↗
- David R. Fogelman · 2 shared papers, 2014 · strength 0.08
- Paper Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab:… DOI 10.1002/cncr.28648↗
- Paper Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analys… DOI 10.1097/mpa.0000000000000095↗
- Nicole F. Neel · 1 shared paper, 2018 · strength 0.06
- Mark J. Ratain Md · 1 shared paper, 2018 · strength 0.06
- Marina Talamonti · 1 shared paper, 2018 · strength 0.06
- David J. Bentrem · 1 shared paper, 2018 · strength 0.06
- Yusuke Nakamura · 1 shared paper, 2018 · strength 0.06
- Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
- Gloria M. Petersen · 1 shared paper, 2018 · strength 0.06
- Robert R. McWilliams · 1 shared paper, 2018 · strength 0.06
- Eileen Mary O'Reilly · 1 shared paper, 2014 · strength 0.04
- Charles S. Fuchs · 1 shared paper, 2014 · strength 0.04
- Mary F. Mulcahy · 1 shared paper, 2014 · strength 0.04
- Mark M. Zalupski · 1 shared paper, 2014 · strength 0.04
- Shubham Pant · 1 shared paper, 2014 · strength 0.04
- Milind M. Javle · 1 shared paper, 2014 · strength 0.04
- Robert A. Wolff · 1 shared paper, 2014 · strength 0.04
- George P. Kim · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.